Jpmorgan Chase & Co »

BioAtla shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of BioAtla (BCAB) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in BioAtla

Tip: Access up to 7 years of quarterly data

All positions including BioAtla held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioAtla by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2026-06-30 $484 121 4.00

More positions owned by Jpmorgan Chase & Co

Nvidia Corporation Common (NVDA)
Apple Common (AAPL)
Microsoft Corp Common (MSFT)
Alphabet Common (GOOG)
Amazon Common (AMZN)
Broadcom Common (AVGO)
State Street Spdr S&p 500 Etf Fund (SPY)
Alphabet Common (GOOGL)
Micron Technology Common (MU)
Meta Platforms Common (META)
Advanced Micro Devices Common (AMD)
Lam Research Corp Common (LRCX)
Tesla Common (TSLA)
Vanguard S&p 500 Etf Fund (VOO)
Eli Lilly & Co Common (LLY)

View all positions for Jpmorgan Chase & Co

Top funds holding BioAtla

Millennium Management
Lido Advisors
Stonepine Capital Management
Acadian Asset Management
Hrt Financial
Geode Capital Management
Deutsche Bank Aktiengesellschaft
BlackRock
Vanguard Capital Management
UBS Group
Vanguard Fiduciary Trust
Tower Research Capital
Forum Finance Group
SBI Securities
Twin Lakes Capital Management

View all funds holding BioAtla